Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alfred Witjes

Showing results (81-90 of 378) with videos related to

Pageof 38
Sort By:
European Urology|December 4, 2014
Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysisEsther H J Hamoen, Maarten de Rooij, J Alfred Witjes, et al.
European Urology|July 29, 2015
Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysisMaarten de Rooij, Esther H J Hamoen, J Alfred Witjes, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 17, 2018
Double-Blind, Randomized, Placebo-controlled Studies Evaluating Apaziquone (E09, Qapzola™) Intravesical Instillation Post Transurethral Resection of Bladder Tumors for the Treatment of Low-risk Non-Muscle Invasive Bladder CancerLawrence Karsh, Neal Shore, Mark Soloway, et al.
BJU International|January 19, 2008
Evaluation of an orthotopic rat bladder urothelial cell carcinoma model by cystoscopyKees Hendricksen, Janneke Molkenboer-Kuenen, Egbert Oosterwijk, et al.
Urologic Oncology|January 18, 2014
Measuring health-related quality of life in men with prostate cancer: A systematic review of the most used questionnaires and their validityEsther H J Hamoen, Maarten De Rooij, J Alfred Witjes, et al.
European Urology Oncology|June 20, 2020
Cutting-edge Management of Muscle-invasive Bladder Cancer in 2020 and a Glimpse into the FutureMalte W Vetterlein, J Alfred Witjes, Yohann Loriot, et al.
International Journal of Cancer|July 1, 2014
The prognostic value of family history among patients with urinary bladder cancerLieke Egbers, Anne J Grotenhuis, Katja K Aben, et al.
The Journal of Urology|March 11, 2005
Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro studyAntoine G van der Heijden, Gerald Verhaegh, Cornelius F J Jansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancerDaphne Hessels, Frank P Smit, Gerald W Verhaegh, et al.
BJU International|January 18, 2019
Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancerDavid D'Andrea, Francesco Soria, Sonja Zehetmayer, et al.
Pageof 38

Showing results (81-90 of 378) with videos related to

Sort By:
Pageof 38
European Urology|December 4, 2014
Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysisEsther H J Hamoen, Maarten de Rooij, J Alfred Witjes, et al.
European Urology|July 29, 2015
Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysisMaarten de Rooij, Esther H J Hamoen, J Alfred Witjes, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 17, 2018
Double-Blind, Randomized, Placebo-controlled Studies Evaluating Apaziquone (E09, Qapzola™) Intravesical Instillation Post Transurethral Resection of Bladder Tumors for the Treatment of Low-risk Non-Muscle Invasive Bladder CancerLawrence Karsh, Neal Shore, Mark Soloway, et al.
BJU International|January 19, 2008
Evaluation of an orthotopic rat bladder urothelial cell carcinoma model by cystoscopyKees Hendricksen, Janneke Molkenboer-Kuenen, Egbert Oosterwijk, et al.
Urologic Oncology|January 18, 2014
Measuring health-related quality of life in men with prostate cancer: A systematic review of the most used questionnaires and their validityEsther H J Hamoen, Maarten De Rooij, J Alfred Witjes, et al.
European Urology Oncology|June 20, 2020
Cutting-edge Management of Muscle-invasive Bladder Cancer in 2020 and a Glimpse into the FutureMalte W Vetterlein, J Alfred Witjes, Yohann Loriot, et al.
International Journal of Cancer|July 1, 2014
The prognostic value of family history among patients with urinary bladder cancerLieke Egbers, Anne J Grotenhuis, Katja K Aben, et al.
The Journal of Urology|March 11, 2005
Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro studyAntoine G van der Heijden, Gerald Verhaegh, Cornelius F J Jansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancerDaphne Hessels, Frank P Smit, Gerald W Verhaegh, et al.
BJU International|January 18, 2019
Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancerDavid D'Andrea, Francesco Soria, Sonja Zehetmayer, et al.
Pageof 38